Literature DB >> 8708163

Relationship between pulmonary oxygen consumption, lung inflammation, and calculated venous admixture in patients with acute lung injury.

P Jolliet1, J B Thorens, L Nicod, C Pichard, U Kyle, J C Chevrolet.   

Abstract

OBJECTIVE: To determine in patients with acute lung injury whether increased pulmonary oxygen consumption (VO2pulm), computed as the difference between oxygen consumption measured by indirect calorimetry (VO2meas) and calculated by the reverse Fick method (VO2Fick), would: (1) correlate with the degree of lung inflammation assessed by bronchoalveolar lavage (BAL); (2) lead to an overestimation of calculated venous admixture (Qva/Qt).
DESIGN: Prospective study.
SETTING: University hospital, medical intensive care unit. INTERVENTION: None. MEASUREMENTS AND
RESULTS: In nine mechanically ventilated patients with acute lung injury (Apache II 12 +/- 5, lung injury score 2 +/- 0.6, mean +/- SD), whole-body VO2 (VO2wb) was determined simultaneously by indirect calorimetry and the reverse Fick technique, after which BAL was immediately performed. VO2meas was significantly higher than VO2Fick (128 +/- 24 and 102 +/- 18 ml/min per m2, respectively, p < 0.001). Median VO2pulm was 25.3 ml/min per m2 (range 1.98-51.5), thus representing 19 +/- 11% of VO2wb. Total BAL cellularity was increased in all patients (median 47, range 24-200 x 10(4)/ml), as was the total polymorphonuclear (PMN) count (median 78 range 5-93 x 10(4)/ml). Macrophage counts were in the normal range. There were raised BAL levels of interleukin-6 (IL-6) (median 945, range 23-1800 ng/ml) and elastase (median 391, range 5-949 ng/ml). Median protein levels were 270 micrograms/ml (range 50-505). There was no correlation between VO2pulm and BAL cellularity, PMNs, elastase, IL-6, or protein. Qva/Qt was 31.7 +/- 8%. Qva/Qt, corrected for the presence of VO2pulm, (Qva/Qtcorr), was 30.3 +/- 8% (P < 0.01 vs Qva/Qt), a 4.2% overestimation due to VO2plum. There was no correlation between Qva/Qt or Qva/Qtcorr and VO2pulm.
CONCLUSIONS: In mechanically ventilated patients with acute lung injury, VO2pulm was increased and led to a 19% underestimation of VO2wb determined by the reverse Fick method, as well as to a 4.2% overestimation of calculated Qva/Qt. Lung inflammatory activity was increased, as assessed by BAL cellularity, IL-6 and elastase levels. However, there was no correlation between VO2pulm and the intensity of pulmonary inflammation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8708163     DOI: 10.1007/BF01700447

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  36 in total

1.  High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis.

Authors:  P M Suter; S Suter; E Girardin; P Roux-Lombard; G E Grau; J M Dayer
Journal:  Am Rev Respir Dis       Date:  1992-05

2.  An expanded definition of the adult respiratory distress syndrome.

Authors:  J F Murray; M A Matthay; J M Luce; M R Flick
Journal:  Am Rev Respir Dis       Date:  1988-09

3.  Ventilation/perfusion indices do not correlate with the difference between oxygen consumption measured by the Fick principle and metabolic monitoring systems in critically ill patients.

Authors:  J A Myburgh; R K Webb; L I Worthley
Journal:  Crit Care Med       Date:  1992-04       Impact factor: 7.598

4.  Procoagulant and fibrinolytic activities in bronchoalveolar fluid of HIV-positive and HIV-negative patients.

Authors:  E De Benedetti; L Nicod; G Reber; C Vifian; P de Moerloose
Journal:  Eur Respir J       Date:  1992-04       Impact factor: 16.671

5.  Indirect calorimetry in the mechanically ventilated patient.

Authors:  M R Levinson; J S Groeger; S Miodownik; C Ray; M F Brennan
Journal:  Crit Care Med       Date:  1987-02       Impact factor: 7.598

6.  O2 consumption by the fick method. Methodologic factors.

Authors:  R Chioléro; P Mavrocordatos; D Bracco; Y Schutz; C Cayeux; J P Revelly
Journal:  Am J Respir Crit Care Med       Date:  1994-05       Impact factor: 21.405

7.  Safety of bronchoalveolar lavage in patients with adult respiratory distress syndrome.

Authors:  K P Steinberg; D R Mitchell; R J Maunder; J A Milberg; M E Whitcomb; L D Hudson
Journal:  Am Rev Respir Dis       Date:  1993-09

Review 8.  Bronchoalveolar lavage.

Authors:  H Y Reynolds
Journal:  Am Rev Respir Dis       Date:  1987-01

9.  Studies on the interaction between phagocytes and tubercle bacilli. I. Observations on the metabolism of guinea pig leucocytes and the influence of phagocytosis.

Authors:  H STAHELIN; E SUTER; M L KARNOVSKY
Journal:  J Exp Med       Date:  1956-07-01       Impact factor: 14.307

10.  Acute lung inflammation: neutrophil elastase versus neutrophils in the bronchoalveolar lavage--neutrophil elastase reflects better inflammatory intensity.

Authors:  A Lengas; V Poletti; L Pacifico; C di Domizio; M Patelli; L Spiga
Journal:  Intensive Care Med       Date:  1994-05       Impact factor: 17.440

View more
  5 in total

1.  Results of the oxygen Fick method in a closed blood circulation model including "total arteriovenous diffusive shunt of oxygen".

Authors:  Mustafa Ozbek; Ahmet Akay
Journal:  Theory Biosci       Date:  2004-09       Impact factor: 1.919

2.  Pulmonary oxygen consumption.

Authors:  J F Nunn
Journal:  Intensive Care Med       Date:  1996-04       Impact factor: 17.440

Review 3.  Novel insights into the aetiology and pathophysiology of increased airway inflammation during COPD exacerbations.

Authors:  Maria Tsoumakidou; Nikolaos M Siafakas
Journal:  Respir Res       Date:  2006-05-22

Review 4.  Clinical review: hemorrhagic shock.

Authors:  Guillermo Gutierrez; H David Reines; Marian E Wulf-Gutierrez
Journal:  Crit Care       Date:  2004-04-02       Impact factor: 9.097

5.  Modeling lung perfusion abnormalities to explain early COVID-19 hypoxemia.

Authors:  Jacob Herrmann; Vitor Mori; Jason H T Bates; Béla Suki
Journal:  Nat Commun       Date:  2020-09-28       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.